How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al Reply

Michael Walsh; Kerstin Westman; David Jayne

doi:10.1002/art.34588

How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al Reply

Michael Walsh, Kerstin Westman, David Jayne

Nephrology

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	3058-3058
Journal	Arthritis and Rheumatism
Volume	64
Issue number	9
DOIs	https://doi.org/10.1002/art.34588
Publication status	Published - 2012

Subject classification (UKÄ)

Clinical Medicine

Access to Document

10.1002/art.34588

Cite this

@article{d93836b4faed4e9ab9dbe533c4ed9584,

title = "How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al Reply",

author = "Michael Walsh and Kerstin Westman and David Jayne",

year = "2012",

doi = "10.1002/art.34588",

language = "English",

volume = "64",

pages = "3058--3058",

journal = "Arthritis and Rheumatism",

issn = "1529-0131",

publisher = "John Wiley & Sons Inc.",

number = "9",

}

TY - JOUR

T1 - How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al Reply

AU - Walsh, Michael

AU - Westman, Kerstin

AU - Jayne, David

PY - 2012

Y1 - 2012

U2 - 10.1002/art.34588

DO - 10.1002/art.34588

M3 - Letter

SN - 1529-0131

VL - 64

SP - 3058

EP - 3058

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

IS - 9

ER -